Eastman Chemical Crecimiento futuro
Future controles de criterios 1/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Eastman Chemical de 8.3% y 4.3% por año respectivamente. Se prevé que el BPA crezca en un 8.7% al año. Se espera que la rentabilidad financiera sea de 16.6% en 3 años.
Información clave
7.5%
Tasa de crecimiento de los beneficios
7.9%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Chemicals | 16.8% |
Tasa de crecimiento de los ingresos | 4.5% |
Rentabilidad financiera futura | 16.9% |
Cobertura de analistas | Good |
Última actualización | 02 May 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Does Eastman Chemical (NYSE:EMN) Have A Healthy Balance Sheet?
May 08It's Probably Less Likely That Eastman Chemical Company's (NYSE:EMN) CEO Will See A Huge Pay Rise This Year
Apr 26Eastman Chemical: Cyclical But Resilient
Apr 25Eastman Chemical Company's (NYSE:EMN) Share Price Is Matching Sentiment Around Its Earnings
Apr 03Is There An Opportunity With Eastman Chemical Company's (NYSE:EMN) 22% Undervaluation?
Feb 22We Think You Should Be Aware Of Some Concerning Factors In Eastman Chemical's (NYSE:EMN) Earnings
Feb 09Here's Why Eastman Chemical (NYSE:EMN) Has A Meaningful Debt Burden
Jan 23Eastman Chemical Company (NYSE:EMN) Screens Well But There Might Be A Catch
Jan 02Eastman Chemical's (NYSE:EMN) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 13Eastman Chemical: Structural Disappointments
Nov 22Is There Now An Opportunity In Eastman Chemical Company (NYSE:EMN)?
Nov 08Eastman Chemical: Shares Are Already Pricing In Recovery
Nov 01These 4 Measures Indicate That Eastman Chemical (NYSE:EMN) Is Using Debt Extensively
Oct 24Eastman Chemical: Sales Volumes Need To Stabilize
Sep 18Eastman Chemical Company (NYSE:EMN) Shares Could Be 37% Below Their Intrinsic Value Estimate
Sep 17Is It Time To Consider Buying Eastman Chemical Company (NYSE:EMN)?
Jul 27Is Eastman Chemical (NYSE:EMN) Using Too Much Debt?
Jul 12Eastman Chemical Benefits From Reversal In Gas And NGL Costs
Jul 03Eastman Chemical Company's (NYSE:EMN) Intrinsic Value Is Potentially 42% Above Its Share Price
Jun 073 Reasons To Consider Eastman Chemical Company
May 30At US$81.79, Is It Time To Put Eastman Chemical Company (NYSE:EMN) On Your Watch List?
Apr 21Here's Why Eastman Chemical (NYSE:EMN) Has A Meaningful Debt Burden
Apr 06Are Investors Undervaluing Eastman Chemical Company (NYSE:EMN) By 28%?
Mar 06Eastman Chemical: A Sporty Valuation But A Bearish Chart Post-Earnings
Feb 26Should You Think About Buying Eastman Chemical Company (NYSE:EMN) Now?
Jan 09Here's Why Eastman Chemical (NYSE:EMN) Can Manage Its Debt Responsibly
Dec 28Eastman Chemical (NYSE:EMN) Is Experiencing Growth In Returns On Capital
Dec 16Eastman Chemical: A Great Long-Term Dividend Stock At The Right Price
Dec 13Eastman Chemical (NYSE:EMN) Is Paying Out A Larger Dividend Than Last Year
Dec 05Does Eastman Chemical (NYSE:EMN) Deserve A Spot On Your Watchlist?
Nov 21Eastman Chemical Non-GAAP EPS of $2.05 beats by $0.05, revenue of $2.71B beats by $140M
Oct 27Is Eastman Chemical Company (NYSE:EMN) Trading At A 41% Discount?
Oct 23Eastman Chemical Company: An Underappreciated ESG Investment
Oct 20While Beaten Down, Eastman Shares Still Have Downside
Oct 11Eastman to provide Ethicon with medical-grade materials for product packaging
Sep 20Here's Why Eastman Chemical (NYSE:EMN) Can Manage Its Debt Responsibly
Sep 15Eastman Chemical slides as Q3 earnings outlook falls short
Sep 13Eastman Chemical Ready To Weather Any Storm
Sep 06Investors Will Want Eastman Chemical's (NYSE:EMN) Growth In ROCE To Persist
Sep 03Here's Why Eastman Chemical (NYSE:EMN) Has Caught The Eye Of Investors
Aug 23Calculating The Intrinsic Value Of Eastman Chemical Company (NYSE:EMN)
Jul 19At US$88.73, Is It Time To Put Eastman Chemical Company (NYSE:EMN) On Your Watch List?
Jul 07Oh, Look - Eastman Chemical Is At Fair Value!
Jun 21Here's Why Eastman Chemical (NYSE:EMN) Can Manage Its Debt Responsibly
Jun 13We Like These Underlying Return On Capital Trends At Eastman Chemical (NYSE:EMN)
Jun 01Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 10,511 | 1,087 | 872 | 1,717 | 10 |
12/31/2025 | 9,906 | 1,039 | 591 | 1,434 | 17 |
12/31/2024 | 9,412 | 889 | 623 | 1,400 | 17 |
3/31/2024 | 9,108 | 925 | 517 | 1,360 | N/A |
12/31/2023 | 9,210 | 894 | 541 | 1,374 | N/A |
9/30/2023 | 9,376 | 585 | 520 | 1,379 | N/A |
6/30/2023 | 9,818 | 708 | 334 | 1,121 | N/A |
3/31/2023 | 10,278 | 692 | 271 | 956 | N/A |
12/31/2022 | 10,580 | 793 | 351 | 975 | N/A |
9/30/2022 | 10,901 | 1,170 | 285 | 948 | N/A |
6/30/2022 | 10,912 | 1,220 | 617 | 1,239 | N/A |
3/31/2022 | 10,781 | 818 | 824 | 1,420 | N/A |
12/31/2021 | 10,476 | 857 | 1,041 | 1,619 | N/A |
9/30/2021 | 9,968 | 511 | 1,144 | 1,595 | N/A |
6/30/2021 | 9,370 | 321 | 1,084 | 1,490 | N/A |
3/31/2021 | 8,641 | 494 | 1,108 | 1,500 | N/A |
12/31/2020 | 8,473 | 478 | 1,059 | 1,455 | N/A |
9/30/2020 | 8,492 | 472 | 1,325 | 1,720 | N/A |
6/30/2020 | 8,695 | 577 | 1,267 | 1,694 | N/A |
3/31/2020 | 9,134 | 808 | 1,260 | 1,680 | N/A |
12/31/2019 | 9,273 | 759 | 1,073 | 1,504 | N/A |
9/30/2019 | 9,444 | 767 | 1,118 | 1,573 | N/A |
6/30/2019 | 9,666 | 913 | 1,070 | 1,552 | N/A |
3/31/2019 | 9,924 | 999 | 1,067 | 1,573 | N/A |
12/31/2018 | 10,151 | 1,080 | 1,015 | 1,543 | N/A |
9/30/2018 | 10,137 | 1,537 | 857 | 1,449 | N/A |
6/30/2018 | 10,055 | 1,448 | 968 | 1,582 | N/A |
3/31/2018 | 9,853 | 1,396 | 926 | 1,570 | N/A |
12/31/2017 | 9,549 | 1,384 | N/A | 1,657 | N/A |
9/30/2017 | 9,375 | 1,009 | N/A | 1,401 | N/A |
6/30/2017 | 9,197 | 918 | N/A | 1,323 | N/A |
3/31/2017 | 9,075 | 881 | N/A | 1,386 | N/A |
12/31/2016 | 9,008 | 854 | N/A | 1,385 | N/A |
9/30/2016 | 9,045 | 862 | N/A | 1,569 | N/A |
6/30/2016 | 9,205 | 886 | N/A | 1,487 | N/A |
3/31/2016 | 9,441 | 928 | N/A | 1,584 | N/A |
12/31/2015 | 9,648 | 848 | N/A | 1,624 | N/A |
9/30/2015 | 9,772 | 740 | N/A | 1,509 | N/A |
6/30/2015 | 9,738 | 694 | N/A | 1,701 | N/A |
3/31/2015 | 9,665 | 687 | N/A | 1,529 | N/A |
12/31/2014 | 9,527 | 749 | N/A | 1,433 | N/A |
9/30/2014 | 9,443 | 1,079 | N/A | 1,452 | N/A |
6/30/2014 | 9,368 | 1,177 | N/A | 1,319 | N/A |
3/31/2014 | 9,348 | 1,151 | N/A | 1,262 | N/A |
12/31/2013 | 9,350 | 1,165 | N/A | 1,297 | N/A |
9/30/2013 | 9,254 | 765 | N/A | 1,234 | N/A |
6/30/2013 | 9,175 | 611 | N/A | 1,160 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (8.3% al año) de EMN es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (8.3% al año) de EMN crezcan menos que el mercado US (14.4% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de EMN crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (4.3% al año) de EMN crezcan más despacio que el mercado de US (8% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 4.3% al año) de EMN crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de EMN sea baja dentro de 3 años (16.6%).